File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Silicone Tube Miniature Drainage Device Implanted under Scleral Flap for the Surgical Treatment of Glaucoma

TitleSilicone Tube Miniature Drainage Device Implanted under Scleral Flap for the Surgical Treatment of Glaucoma
Authors
KeywordsPrimary open-angle glaucoma
silicone tube
filtering surgery
intraocular pressure
miniature drainage device
Issue Date2020
PublisherTaylor & Francis. The Journal's web site is located at http://www.tandfonline.com/icey
Citation
Current Eye Research, 2020, v. 45 n. 7, p. 820-826 How to Cite?
AbstractPurpose: To evaluate the safety and efficacy of a silicone tube miniature drainage device implanted under scleral flap for the surgical treatment of primary open-angle glaucoma (POAG). Methods: This is a non-randomized prospective study. Patients with a minimum follow-up of 12 months were analyzed. Demographic information, preoperative and postoperative data including intraocular pressure (IOP), number of medications and complications were recorded. Results: A total of 33 eyes of 33 patients were included in the analysis. Mean postoperative follow-up was 29.5 ± 6.9 months (range 18–50 months). The mean preoperative IOP was 25.8 ± 7.3 mmHg and decreased to 14.9 ± 4.3, 14.2 ± 3.4 and 14.9 ± 3.3 mmHg at 1 year, 2 years and last follow-up after surgery. The number of medications was decreased from 3.1 ± 1.3 preoperatively to 0.2 ± 0.7, 0.4 ± 0.9 and 0.4 ± 1.0 at 1 year, 2 years and last follow-up, respectively, after surgery. Only six (18.2%) patients used glaucoma medications at last visit. The complete success rates were 87.9% and 78.6%, respectively, at 1 and 2 years postoperatively. The operation-related complications were rare. Conclusions: The silicone tube miniature drainage device implanted under the scleral flap was found to be a relatively safe and effective surgery for the treatment of POAG. Longer follow-up periods and larger sample sizes are expected.
Persistent Identifierhttp://hdl.handle.net/10722/282854
ISSN
2019 Impact Factor: 1.754
2015 SCImago Journal Rankings: 0.975
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorFang, A-
dc.contributor.authorNie, L-
dc.contributor.authorWang, P-
dc.contributor.authorZheng, J-
dc.contributor.authorChan, YK-
dc.contributor.authorZhang, Q-
dc.contributor.authorLiang, Y-
dc.contributor.authorJia, Q-
dc.date.accessioned2020-06-05T06:22:20Z-
dc.date.available2020-06-05T06:22:20Z-
dc.date.issued2020-
dc.identifier.citationCurrent Eye Research, 2020, v. 45 n. 7, p. 820-826-
dc.identifier.issn0271-3683-
dc.identifier.urihttp://hdl.handle.net/10722/282854-
dc.description.abstractPurpose: To evaluate the safety and efficacy of a silicone tube miniature drainage device implanted under scleral flap for the surgical treatment of primary open-angle glaucoma (POAG). Methods: This is a non-randomized prospective study. Patients with a minimum follow-up of 12 months were analyzed. Demographic information, preoperative and postoperative data including intraocular pressure (IOP), number of medications and complications were recorded. Results: A total of 33 eyes of 33 patients were included in the analysis. Mean postoperative follow-up was 29.5 ± 6.9 months (range 18–50 months). The mean preoperative IOP was 25.8 ± 7.3 mmHg and decreased to 14.9 ± 4.3, 14.2 ± 3.4 and 14.9 ± 3.3 mmHg at 1 year, 2 years and last follow-up after surgery. The number of medications was decreased from 3.1 ± 1.3 preoperatively to 0.2 ± 0.7, 0.4 ± 0.9 and 0.4 ± 1.0 at 1 year, 2 years and last follow-up, respectively, after surgery. Only six (18.2%) patients used glaucoma medications at last visit. The complete success rates were 87.9% and 78.6%, respectively, at 1 and 2 years postoperatively. The operation-related complications were rare. Conclusions: The silicone tube miniature drainage device implanted under the scleral flap was found to be a relatively safe and effective surgery for the treatment of POAG. Longer follow-up periods and larger sample sizes are expected.-
dc.languageeng-
dc.publisherTaylor & Francis. The Journal's web site is located at http://www.tandfonline.com/icey-
dc.relation.ispartofCurrent Eye Research-
dc.rightsAOM/Preprint Before Accepted: his article has been accepted for publication in [JOURNAL TITLE], published by Taylor & Francis. AOM/Preprint After Accepted: This is an [original manuscript / preprint] of an article published by Taylor & Francis in [JOURNAL TITLE] on [date of publication], available online: http://www.tandfonline.com/[Article DOI]. Accepted Manuscript (AM) i.e. Postprint This is an Accepted Manuscript of an article published by Taylor & Francis in [JOURNAL TITLE] on [date of publication], available online: http://www.tandfonline.com/[Article DOI].-
dc.subjectPrimary open-angle glaucoma-
dc.subjectsilicone tube-
dc.subjectfiltering surgery-
dc.subjectintraocular pressure-
dc.subjectminiature drainage device-
dc.titleSilicone Tube Miniature Drainage Device Implanted under Scleral Flap for the Surgical Treatment of Glaucoma-
dc.typeArticle-
dc.identifier.emailChan, YK: josephyk@connect.hku.hk-
dc.identifier.authorityChan, YK=rp02536-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1080/02713683.2019.1701687-
dc.identifier.pmid32090623-
dc.identifier.scopuseid_2-s2.0-85086346034-
dc.identifier.hkuros310046-
dc.identifier.volume45-
dc.identifier.issue7-
dc.identifier.spage820-
dc.identifier.epage826-
dc.identifier.isiWOS:000515488800001-
dc.publisher.placeUnited Kingdom-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats